Product Information

MOMETASONE FUROATE 50 MCG SPRY is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $1.5899 per GM under NDC 65162089129. Its NADAC has been published 488 times since Apr 19, 2017.

FDA first approved this application on Apr 3, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MOMETASONE FUROATE 50 MCG SPRY

Mometasone
$1.5899per GM

Strength

50 ug/1

NDC

65162089129

Classification

Generic

Dosage Form

SPRAY, METERED

Route

NASAL

Effective Date

8/19/2026

Active Ingredients

MOMETASONE FUROATE

Approval Type

Generic (ANDA)

FDA Application

ANDA207989

FDA Approved

4/3/2017

TE Code

AB

On Market Since

4/4/2017

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for MOMETASONE FUROATE 50 MCG SPRY has been published 488 times since Apr 19, 2017, and over the history we have for it it has declined 77.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.5899 per GM
All-time high$6.9632 (May 10, 2017)
All-time low$1.5899 (Aug 19, 2026)
52-week high$1.7874
52-week low$1.5899
Median price$2.2360
Average price$2.5760
Largest weekly change+15.0% (Jun 19, 2024)
Weeks tracked488
Tracking sinceApr 19, 2017

Price History

1W

-1.0%

1M

-1.0%

3M

-1.5%

6M

-5.2%

1Y

-9.1%

3Y

-25.1%

5Y

-33.1%

All

-77.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Mometasone market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of MOMETASONE FUROATE 50 MCG SPRY?

The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 50 MCG SPRY, manufactured by Amneal Pharmaceuticals LLC, is $1.5899 per GM (NDC 65162089129), effective Aug 19, 2026.

How has the price of MOMETASONE FUROATE 50 MCG SPRY changed over time?

Over the history we have for it, the NADAC for MOMETASONE FUROATE 50 MCG SPRY has declined 77.2%. It has been tracked across 488 weekly CMS publications since Apr 19, 2017.

What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 50 MCG SPRY?

Since Apr 19, 2017, the NADAC for MOMETASONE FUROATE 50 MCG SPRY has ranged from a low of $1.5899 (Aug 19, 2026) to a high of $6.9632 (May 10, 2017), with a median of $2.2360 per GM.

Are there cheaper alternatives to MOMETASONE FUROATE 50 MCG SPRY?

No other NADAC-published product currently shares the active ingredient and strength of MOMETASONE FUROATE 50 MCG SPRY in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures MOMETASONE FUROATE 50 MCG SPRY?

MOMETASONE FUROATE 50 MCG SPRY (NDC 65162089129) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.